HNRNPL Gene

HNRNPL Gene

Introduction

HNRNPL (Heterogeneous Nuclear Ribonucleoprotein L) encodes an RNA-binding protein that plays critical roles in post-transcriptional gene regulation[@liu2015]. As a member of the hnRNP family, HNRNPL is involved in alternative splicing, mRNA stability, translation regulation, and various aspects of RNA processing. The protein contains multiple RNA recognition motifs (RRMs) that enable it to bind to specific RNA sequences and participate in the formation of ribonucleoprotein complexes essential for proper cellular function.

HNRNPL has been increasingly recognized for its important roles in neuronal function and neurodegeneration[@rahman2015]. Dysregulation of HNRNPL and its associated splicing targets has been implicated in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other neurological disorders. This page provides a comprehensive overview of HNRNPL's molecular function, structural features, disease associations, and therapeutic implications.

Gene Overview

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | HNRNPL |
| Full Name | Heterogeneous Nuclear Ribonucleoprotein L |
| Alternative Names | hnRNP L, Plectin |
| Chromosomal Location | 19q13.31 |
| NCBI Gene ID | 3191 |
| OMIM ID | 607073 |
| Ensembl ID | ENSG00000130816 |
| UniProt ID | P14866 |
| Protein Length | 589 amino acids |
| Molecular Weight | ~64 kDa |
| Associated Diseases | ALS, AD, PD, Autoimmune disease, Cancer |

</div>

HNRNPL Gene

Introduction

HNRNPL (Heterogeneous Nuclear Ribonucleoprotein L) encodes an RNA-binding protein that plays critical roles in post-transcriptional gene regulation[@liu2015]. As a member of the hnRNP family, HNRNPL is involved in alternative splicing, mRNA stability, translation regulation, and various aspects of RNA processing. The protein contains multiple RNA recognition motifs (RRMs) that enable it to bind to specific RNA sequences and participate in the formation of ribonucleoprotein complexes essential for proper cellular function.

HNRNPL has been increasingly recognized for its important roles in neuronal function and neurodegeneration[@rahman2015]. Dysregulation of HNRNPL and its associated splicing targets has been implicated in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other neurological disorders. This page provides a comprehensive overview of HNRNPL's molecular function, structural features, disease associations, and therapeutic implications.

Gene Overview

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | HNRNPL |
| Full Name | Heterogeneous Nuclear Ribonucleoprotein L |
| Alternative Names | hnRNP L, Plectin |
| Chromosomal Location | 19q13.31 |
| NCBI Gene ID | 3191 |
| OMIM ID | 607073 |
| Ensembl ID | ENSG00000130816 |
| UniProt ID | P14866 |
| Protein Length | 589 amino acids |
| Molecular Weight | ~64 kDa |
| Associated Diseases | ALS, AD, PD, Autoimmune disease, Cancer |

</div>

Molecular Structure

Domain Organization

HNRNPL contains several functional domains[@house2010]:

• RRM1: Primary RNA binding
• RRM2: Auxiliary binding
• RRM3: Interaction with regulatory factors

Structure-Function Relationships

The RRMs of HNRNPL recognize specific RNA sequences:

• CA-rich elements (CARE): Primary binding sites
• AU-rich elements (ARE): Found in 3' UTRs of mRNAs
• Specific exonic splicing enhancers (ESE): Regulate alternative splicing

Biological Functions

Alternative Splicing Regulation

HNRNPL is a key regulator of alternative splicing[@liu2015]:

Key Splicing Functions:

• Exon Inclusion/Exclusion: HNRNPL binding to exonic splicing enhancers or silencers
• Alternative 5' and 3' Splice Site Selection: Modulates splice site choice
• Intron Retention: Controls the inclusion of introns in mature transcripts

mRNA Stability and Translation

Beyond splicing, HNRNPL regulates[@hutchinson2012]:

Telomere Maintenance

HNRNPL interacts with the telomerase complex:

• Associates with TER (telomerase RNA)
• Modulates telomerase activity
• Affects telomere length maintenance

Stress Response and RNA Granules

HNRNPL is recruited to stress granules under cellular stress[@liu2020]:

Expression Pattern

Tissue Distribution

HNRNPL shows ubiquitous expression across tissues:

| Tissue | Expression Level |
|---------|------------------|
| Brain (cortex, hippocampus) | High |
| Heart | High |
| Liver | High |
| Lung | Moderate |
| Kidney | Moderate |
| Skeletal muscle | Moderate |
| Testis | High |
| Most tissues | Moderate-high |

Brain Expression

Within the nervous system, HNRNPL is expressed in[@rahman2015]:

• Cortex: Pyramidal neurons (layer 2-6)
• Hippocampus: CA1, CA3, dentate gyrus
• Cerebellum: Purkinje cells
• Substantia nigra: Dopaminergic neurons
• Spinal cord: Motor neurons
• Astrocytes: Astrocytic glia

Cellular Localization

• Nucleus: Predominantly nuclear (both nucleoplasm and nucleolus)
• Cytoplasm: Subset in cytoplasmic compartment
• Stress granules: Translocates under stress conditions

Role in Neurodegeneration

Amyotrophic Lateral SLS (ALS)

HNRNPL is significantly implicated in ALS pathogenesis[@zong2019][@kim2024]:

Key Evidence:

• HNRNPL mutations are associated with ALS risk
• Altered splicing patterns in ALS patient tissue
• Dysregulated stress granule dynamics in models

Alzheimer's Disease

HNRNPL contributes to AD through multiple mechanisms[@chen2017]:

Key Evidence:

• HNRNPL expression is altered in AD brains
• Splicing of tau isoforms is dysregulated
• Co-localization with AD pathology

Parkinson's Disease

HNRNPL plays important roles in PD pathogenesis[@wang2022]:

Other Neurodegenerative Conditions

• Huntington's Disease: Altered HNRNPL and splicing patterns
• Frontotemporal Dementia: Related to TDP-43 pathology
• Multiple Sclerosis: Autoimmune associations

Mechanisms of Neurodegeneration

Molecular Pathways

HNRNPL dysfunction leads to neurodegeneration through:

Key Splicing Targets

HNRNPL regulates splicing of several neurodegeneration-relevant genes:

| Gene | Function | HNRNPL Effect |
|------|----------|---------------|
| MAPT | Tau isoforms | Alternative splicing |
| SNCA | α-synuclein | Transcript variants |
| SOD1 | Antioxidant | Splicing regulation |
| TDP-43 | RNA processing | Interaction |
| VAPB | ER function | Splicing |

Protein Interactions

HNRNPL interacts with several key proteins:

| Partner | Interaction | Context |
|---------|-------------|---------|
| HNRNPA1 | Direct binding | Splicing regulation |
| HNRNPA2B1 | Complex formation | RNA processing |
| TDP-43 | Functional interaction | ALS pathology |
| SRSF1 | Co-regulation | Splicing |
| PABPN1 | Binding | mRNA processing |

Therapeutic Implications

Therapeutic Strategies

Targeting HNRNPL represents a promising approach[@zhou2023]:

Challenges

• Splicing Specificity: Achieving target-specific effects
• Delivery: Crossing the blood-brain barrier
• Balance: Maintaining normal splicing functions

Molecular Mechanisms

RNA Recognition Motif Function

HNRNPL's RRMs (RNA Recognition Motifs) enable precise RNA binding[@house2010]:

RRM1 (aa 150-220):

• Primary RNA binding site
• Recognizes CA-rich elements (CARE)
• Essential for splicing regulation

• Auxiliary RNA binding
• Enhances specificity
• Stabilizes RRM1 binding

• Protein-protein interactions
• Regulatory functions
• Coordination with other splicing factors

Splicing Regulation Complexes

HNRNPL functions in multiple splicing complexes:

| Complex | Function | HNRNPL Role |
|---------|----------|-------------|
| NTC | Core spliceosome | Activator |
| HshnRNP | hnRNP particles | Assembly |
| SR complex | Splicing regulation | Co-activator |
| EXM | Exon definition | Enhancer binding |

Post-Translational Modifications

HNRNPL activity is regulated by:

• Phosphorylation: Ser/Thr kinases modulate RRM binding
• Methylation: Arginine methylation affects RNA binding
• Sumoylation: Alters protein interactions
• Acetylation: Regulates nuclear-cytoplasmic shuttling

Disease Mechanisms

ALS Pathogenesis

HNRNPL dysfunction contributes to ALS through multiple pathways[@zong2019][@kim2024]:

Splicing Dysregulation:

• Aberrant splicing of TDP-43 target genes
• Intron retention in essential transcripts
• Loss of functional protein isoforms

• Persistent stress granule formation
• Sequestration of translation machinery
• Impaired stress response resolution

• Functional overlap with TDP-43
• Compensatory mechanisms
• Shared target transcripts

Alzheimer's Disease Mechanisms

HNRNPL contributes to AD through[@chen2017]:

• Alternative splicing of MAPT exons 2, 3, 10
• 3R/4R tau ratio imbalance
• Promotes aggregation

• Regulation of APP alternative splicing
• Affects Aβ production
• Modulates amyloid pathology

• Splicing of synaptic protein transcripts
• Altered synaptic plasticity genes
• Circuit dysfunction

Parkinson's Disease Mechanisms

HNRNPL in PD involves[@wang2022]:

• Alternative splicing of SNCA exon 3
• Modulates aggregation propensity
• Affects toxicity

• Splicing of mitochondrial proteins
• Impaired energy metabolism
• Increased oxidative stress

• Region-specific effects
• Enhanced susceptibility
• Progressive degeneration

Research Models

Cell Culture Models

• Neuronal cell lines: SH-SY5Y, PC12
• Primary neurons: Cortical, dopaminergic
• iPSC-derived: Patient-specific neurons
• Astrocytes: Glial contributions

Animal Models

• C. elegans: hnrnpl knockdown
• Drosophila: hnrnpl mutants
• Zebrafish: Morpholino knockdowns
• Mice: Conditional knockouts

Molecular Tools

| Tool | Application | Status |
|------|-------------|--------|
| siRNA | Knockdown | Validated |
| CRISPR | Gene editing | In development |
| ASOs | Splice modulation | Preclinical |
| Small molecules | Target modulation | Discovery |

Clinical Implications

Diagnostic Biomarkers

HNRNPL as a biomarker:

• Blood: HNRNPL levels in plasma/serum
• CSF: Cerebrospinal fluid measurement
• Tissue: Brain biopsy in research

Therapeutic Development

Splice-Switching Oligonucleotides (SSOs):

• Correct aberrant splicing patterns
• Target-specific transcript modulation
• Clinical trials in other diseases

• Enhance HNRNPL function
• Prevent pathological interactions
• Promote normal splicing

Clinical Trials

Currently no direct HNRNPL-targeted trials, but related approaches:

• Antisense oligonucleotides in ALS
• Splicing modulators in neurodegeneration
• RNA-targeting therapies

Comparison with Other hnRNPs

| Protein | Primary Function | Disease Links |
|---------|-----------------|---------------|
| HNRNPL | Splicing regulation | ALS, AD, PD |
| HNRNPA1 | Telomere maintenance | ALS, Inclusion body myositis |
| HNRNPA2B1 | RNA processing | ALS, PD |
| HNRNPQ | Translation | ALS |
| HNRNPD | mRNA stability | Cancer, ALS |

Summary

HNRNPL (Heterogeneous Nuclear Ribonucleoprotein L) is an RNA-binding protein with critical roles in alternative splicing, mRNA stability, and stress response. Through its three RNA recognition motifs, HNRNPL recognizes CA-rich elements and regulates the splicing of numerous transcripts relevant to neurodegeneration.

Dysregulation of HNRNPL contributes to multiple neurodegenerative diseases including ALS, Alzheimer's disease, and Parkinson's disease. In ALS, HNRNPL mutations and altered splicing patterns contribute to disease pathogenesis. In AD, HNRNPL affects tau splicing and APP processing. In PD, HNRNPL modulates α-synuclein transcript variants and mitochondrial function.

Therapeutic targeting of HNRNPL through splicing modulators, gene therapy, and RNA-targeting approaches represents a promising strategy for neurodegenerative disease treatment. Understanding the precise mechanisms of HNRNPL dysfunction will be essential for developing effective therapies.

Mechanistic Pathways in Neurodegeneration

HNRNPL in Tau Pathology (AD)

HNRNPL in α-Synuclein Regulation (PD)

HNRNPL and ALS Pathogenesis

| Mechanism | Effect | Therapeutic Target |
|-----------|--------|-------------------|
| TDP-43 interaction | Compensatory splicing regulation | Splicing modulators |
| Stress granule dynamics | Altered stress response | Granule inhibitors |
| Motor neuron splicing | Loss of functional isoforms | ASO therapy |
| Mitochondrial transcripts | Energy metabolism defects | Gene therapy |

Key Research Findings

Cross-Links to Related Topics

Related Genes and Proteins

• [HNRNPA1](/genes/hnrnpa1-gene) - Related hnRNP
• [HNRNPA2B1](/genes/hnrnpa2b1-gene) - hnRNP A2/B1
• [TARDBP](/genes/tardbp-gene) - TDP-43

Related Mechanisms

• [RNA Processing](/mechanisms/rna-processing) - Core mechanism
• [Alternative Splicing](/mechanisms/alternative-splicing) - Splicing
• [Stress Granules](/mechanisms/stress-granules) - RNA granules
• [Protein Quality Control](/mechanisms/protein-quality-control-network) - Quality control

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease) - AD page
• [Parkinson's Disease](/diseases/parkinsons-disease) - PD page
• [ALS](/diseases/amyotrophic-lateral-sclerosis) - ALS page

See Also

• [Genes Index](/genes-index)
• [RNA Binding Proteins](/mechanisms/rna-binding-proteins)
• [Alternative Splicing](/mechanisms/alternative-splicing)
• [Stress Response Mechanisms](/mechanisms/stress-response)
• [Synaptic Function](/mechanisms/synaptic-function)

External Links

• [NCBI Gene: HNRNPL](https://www.ncbi.nlm.nih.gov/gene/3191)
• [UniProt: P14866](https://www.uniprot.org/uniprotkb/P14866)
• [OMIM: 607073](https://www.omim.org/entry/607073)
• [Ensembl: HNRNPL](https://www.ensembl.org/Homo_species/Gene/Summary?g=ENSG00000130816)

References